Literature DB >> 17959138

Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis.

B C Lewis1, P I Mackenzie, J O Miners.   

Abstract

CYP1A1 homology models based on the CYP2C5 and a composite of CYP2C5, CYP2C8, and CYP2C9 X-ray crystal structures were compared to a model generated using the recently published coordinates of CYP1A2. The model using the CYP1A2 coordinates, CYP1A1-(1A2), gave near ideal stereochemical quality and was favored energetically. Docking studies identified the active-site residues potentially involved in binding of the prototypic CYP1A1 substrate 7-ethoxyresorufin. CYP1A1 mutants S122A, F123A, F224A, A317Y, T321G, and I386G were generated to explore the roles of these residues in 7-ethoxyresorufin binding and turnover, and generally confirmed the importance of aromatic interactions over hydrogen bonding in orientating 7-ethoxyresrufin in a catalytically favorable orientation. Although 7-ethoxyresorufin O-deethylation by CYP1A1 and several mutants exhibited substrate inhibition, it is unlikely that inhibition arises from the simultaneous binding of two substrates within the active-site given the geometry of the active site-cavity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17959138     DOI: 10.1016/j.abb.2007.09.014

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Comparative proteomics among cytochrome p450 family 1 for differential substrate specificity.

Authors:  Siddharth S Kesharwani; Prajwal P Nandekar; Preeti Pragyan; Abhay T Sangamwar
Journal:  Protein J       Date:  2014-12       Impact factor: 2.371

2.  Structural features of cytochrome P450 1A associated with the absence of EROD activity in liver of the loricariid catfish Pterygoplichthys sp.

Authors:  Thiago E M Parente; Mauro F Rebelo; Manuela L da-Silva; Bruce R Woodin; Jared V Goldstone; Paulo M Bisch; Francisco J R Paumgartten; John J Stegeman
Journal:  Gene       Date:  2011-08-05       Impact factor: 3.688

3.  Application of molecular modeling for prediction of substrate specificity in cytochrome P450 1A2 mutants.

Authors:  Youbin Tu; Rahul Deshmukh; Meena Sivaneri; Grazyna D Szklarz
Journal:  Drug Metab Dispos       Date:  2008-08-14       Impact factor: 3.922

4.  CYP1A1 I462V polymorphism is associated with reduced genotoxicity in yeast despite positive association with increased cancer risk.

Authors:  Julian Freedland; Cinzia Cera; Michael Fasullo
Journal:  Mutat Res       Date:  2017-02-20       Impact factor: 2.433

Review 5.  Regulation of Human Cytochrome P4501A1 (hCYP1A1): A Plausible Target for Chemoprevention?

Authors:  Rebeca Santes-Palacios; Diego Ornelas-Ayala; Noel Cabañas; Ana Marroquín-Pérez; Alexis Hernández-Magaña; Sitlali Del Rosario Olguín-Reyes; Rafael Camacho-Carranza; Jesús Javier Espinosa-Aguirre
Journal:  Biomed Res Int       Date:  2016-12-26       Impact factor: 3.411

Review 6.  Structure-Based Drug Design for Cytochrome P450 Family 1 Inhibitors.

Authors:  Zbigniew Dutkiewicz; Renata Mikstacka
Journal:  Bioinorg Chem Appl       Date:  2018-07-25       Impact factor: 7.778

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.